
Download Files:
Mezigdomide
SKU
HY-129395-10 mg
Category Reference compound
Tags Apoptosis;E1/E2/E3 Enzyme;Molecular Glues, Apoptosis;Metabolic Enzyme/Protease;PROTAC, Cancer
$350 – $2,250
Products Details
Product Description
– Mezigdomide (CC-92480), a cereblon E3 ubiquitin ligase modulating agent (CELMoD), acts as a molecular glue. Mezigdomide shows high affinity to cereblon, resulting in potent antimyeloma activity[1].
Web ID
– HY-129395
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Cancer-programmed cell death
Molecular Formula
– C32H30FN5O4
References
– [1]Nooka AK, et al. Mechanism of Action and Novel IMiD-Based Compounds and Combinations in Multiple Myeloma. Cancer J. 2019 Jan/Feb;25(1):19-31.
CAS Number
– 2259648-80-9
Molecular Weight
– 567.61
Compound Purity
– 99.68
SMILES
– N#CC1=CC=C(N2CCN(CC3=CC=C(COC4=CC=CC5=C4CN([C@@H](CC6)C(NC6=O)=O)C5=O)C=C3)CC2)C(F)=C1
Clinical Information
– Phase 3
Research Area
– Cancer
Solubility
– DMSO : 5 mg/mL (ultrasonic;warming;heat to 60°C)
Target
– Apoptosis;E1/E2/E3 Enzyme;Molecular Glues
Pathway
– Apoptosis;Metabolic Enzyme/Protease;PROTAC
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.